In situ vaccination caused by diverse irradiation-driven cell death programs

Area of Science:

• Oncology
• Immunology
• Radiation Biology

Background:

• Growing interest in irradiation's effect on immune activation, including the abscopal effect.
• Radiotherapy and immunotherapy combinations show success in cancer treatment.
• Hypothesis: Irradiation induces immunogenic cell death (ICD) in tumor cells, activating the immune system.

Purpose of the Study:

• Review fundamental knowledge of irradiation-induced ICD.
• Describe the link between cell death pathways and irradiation-driven immune activation.
• Focus on therapeutic potential of exploiting cell death programs in radiotherapy.

Main Methods:

• Literature review of irradiation-induced cell death mechanisms.
• Analysis of the relationship between cell death pathways and immune responses.
• Summary of immunomodulatory effects of cell death programs in combined treatments.

Main Results:

• Irradiation can induce various forms of ICD, acting as an in situ vaccine.
• Different cell death programs significantly influence irradiation-induced immune activation.
• Understanding cell death transitions is crucial for treatment optimization.

Conclusions:

• Exploiting irradiation-induced ICD offers therapeutic value in cancer treatment.
• Immunomodulatory effects of cell death programs impact combined radiotherapy and immunotherapy.
• Evaluating cell death pathways can guide novel strategies for cancer therapy.